Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas (2023)
- Authors:
- USP affiliated authors: CASTRO JUNIOR, GILBERTO DE - FM ; KOWALSKI, LUIZ PAULO - FM
- Unidade: FM
- Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS; INIBIDORES DE ENZIMAS; CÉLULAS-TRONCO; QUIMIOTERAPIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American journal of cancer research
- ISSN: 2156-6976
- Volume/Número/Paginação/Ano: v. 13, n. 4, p. 1547-1559, 2023
-
ABNT
SILVA, Luan Cesar et al. Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas. American journal of cancer research, v. 13, n. 4, p. 1547-1559, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54550. Acesso em: 11 jun. 2024. -
APA
Silva, L. C., Borgato, G. B., Wagner, V. P., Martins, M. D., Santos-Silva, A. R. dos, Castro Junior, G. de, et al. (2023). Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas. American journal of cancer research, 13( 4), 1547-1559. Recuperado de https://observatorio.fm.usp.br/handle/OPI/54550 -
NLM
Silva LC, Borgato GB, Wagner VP, Martins MD, Santos-Silva AR dos, Castro Junior G de, Kowalski LP, Squarize CH, Vargas PA, Castilho RM. Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas [Internet]. American journal of cancer research. 2023 ; 13( 4): 1547-1559.[citado 2024 jun. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54550 -
Vancouver
Silva LC, Borgato GB, Wagner VP, Martins MD, Santos-Silva AR dos, Castro Junior G de, Kowalski LP, Squarize CH, Vargas PA, Castilho RM. Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas [Internet]. American journal of cancer research. 2023 ; 13( 4): 1547-1559.[citado 2024 jun. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54550 - Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic [Editorial]
- Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy
- Head and neck surgery recommendations during the COVID-19 pandemic [Carta]
- Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: a systematic review and meta-analysis
- Effect of the COVID-19 Pandemic on the Activity of Physicians Working in the Areas of Head and Neck Surgery and Otorhinolaryngology
- Diagnóstico de mutações ativadoras do gene EGFR em adenocarcinomas pulmonares: caracterização e implicações clínicas
- Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-Positive NSCLC: primary efficacy results from the ASCEND-8 study
- Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
- Manual de oncologia torácica
- Lung Cancer in Brazil [Editorial]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
